Mutual of America Capital Management LLC Sells 663 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Mutual of America Capital Management LLC decreased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 2.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 23,825 shares of the medical device company’s stock after selling 663 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Cooper Companies were worth $2,190,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Fulton Bank N.A. boosted its holdings in shares of Cooper Companies by 3.0% during the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after acquiring an additional 109 shares in the last quarter. Mather Group LLC. boosted its stake in shares of Cooper Companies by 7.4% during the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after purchasing an additional 133 shares in the last quarter. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock worth $93,000 after purchasing an additional 136 shares during the last quarter. Greenleaf Trust increased its stake in shares of Cooper Companies by 5.0% in the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after buying an additional 139 shares during the period. Finally, UMB Bank n.a. raised its holdings in Cooper Companies by 22.5% in the 4th quarter. UMB Bank n.a. now owns 773 shares of the medical device company’s stock valued at $71,000 after buying an additional 142 shares during the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Price Performance

Cooper Companies stock opened at $85.00 on Friday. The stock has a market capitalization of $16.96 billion, a price-to-earnings ratio of 43.59, a PEG ratio of 2.25 and a beta of 1.02. The Cooper Companies, Inc. has a 52-week low of $82.61 and a 52-week high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock’s 50 day moving average price is $92.52 and its two-hundred day moving average price is $99.45.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. On average, equities analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Morgan Stanley reduced their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Piper Sandler reissued an “overweight” rating and issued a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a research note on Friday. Stifel Nicolaus lowered their target price on Cooper Companies from $115.00 to $105.00 and set a “buy” rating for the company in a research report on Friday. Wells Fargo & Company upped their price target on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Finally, JPMorgan Chase & Co. lowered their price objective on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Friday. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $111.89.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.